International Rare Disease Patent Applications Published in April 2021

These PCT patent documents covering potential treatments, diagnostics, or animal and cell culture models for rare diseases as a central theme have been extracted from the WIPO PatentScope database. Abstracts are shortened from the published ones. This a free H. M. Pharma Consultancy service; please cite it if you use it as a starting point for your own research. Nothing in this post should be con...
Read More

REPOSCOPE – The Landscape of Current Drug Repurposing Opportunities

H.M. Pharma Consultancy is building a new tool: a database of drug repurposing claims, suggestions, and developments. For the moment we are attempting to capture and link everything of relevance that has been published since 2010, and we also integrate whatever earlier material we detect. At the heart of this effort is the collection of drug repurposing patent applications that we have captured –...
Read More

International Rare Disease Patent Applications Published in March 2021

These PCT patent documents covering potential treatments, diagnostics, or animal and cell culture models for rare diseases as a central theme have been extracted from the WIPO PatentScope database. Abstracts are shortened from the published ones. This a free H. M. Pharma Consultancy service; please cite it if you use it as a starting point for your own research. Nothing in this post should be con...
Read More

OSINT – The Mantra of Our Science-Based Drug Development Intelligence

OSINT - Open Source Intelligence. It sounds like something the spooks do, and actually it encompasses much of what an intelligence agency does. However, OSINT is at work everywhere: it covers collection of freely accessible data or information, which are then processed and analyzed to gain new insights. By definition, OSINT uses "passive sensors" only: no wiretapping, no hacking, no infiltration, ...
Read More

International Rare Disease Patent Applications Published in February 2021

These PCT patent documents covering potential treatments, diagnostics, or animal and cell culture models for rare diseases as a central theme have been extracted from the WIPO PatentScope database. Abstracts are as published. This a free H. M. Pharma Consultancy service; please cite it if you use it as a starting point for your own research. Nothing in this post should be constructed as represent...
Read More

International Rare Disease Patent Applications Published in January 2021

These PCT patent documents covering potential treatments, diagnostics, or animal and cell culture models for rare diseases as a central theme have been extracted from the WIPO PatentScope database. Abstracts are as published. This a free H. M. Pharma Consultancy service; please cite it if you use it as a starting point for your own research. Nothing in this post should be constructed as represent...
Read More

International Rare Disease Patent Applications Published in December 2020

These PCT patent documents covering potential treatments, diagnostics, or animal and cell culture models for rare diseases as a central theme have been extracted from the WIPO PatentScope database. Abstracts are as published. This a free H. M. Pharma Consultancy service; please cite it if you use it as a starting point for your own research. Nothing in this post should be constructed as represent...
Read More

International Rare Disease Patent Applications Published in November 2020

These PCT patent documents covering potential treatments, diagnostics, or animal and cell culture models for rare diseases as a central theme have been extracted from the WIPO PatentScope database. Abstracts are as published. This a free H. M. Pharma Consultancy service; please cite it if you use it as a starting point for your own research. Nothing in this post should be constructed as represent...
Read More

Boosting into the post-Covid era

2020… Ah, what a ride. And no, this is not another text piece joining the chorus of weeping, complaining, and interpreting how the Covid-19 pandemic has devastated drug developers – except those who had an approved antiviral drug available that had some effect against SARS-CoV2. And of course, except those who suddenly fell in love with drug repurposing and actually identified a marketed drug ...
Read More

A Summary of Recent Drug Repurposing Patent Applications (Part II)

We continue our series with a summary of the Q1/2019 drug repurposing patent discussions in ASSAY and Drug Development Technologies (ahead of print, DOI link here).   WO/2019/004808 (Université Mohammed V Rabat (Morocco) Pyridostigmin restores peripheral nervous system balance in neurodegenerative diseases or after neurotrauma WO/2019/008141 INSERM, CNRS, Université Paris Descarte...
Read More